Sequenom's Quality of Life: Cash Versus Burn Rates (SQNM)
Sequenom Inc. (NASDAQ: SQNM) gave an earnings report that only highlights its cash on hand versus a total expected cash burn rate. The troubled diagnostics is down over 11% at $5.35 right after the...
View ArticleBIO Survey Shows Expected Opportunities Abound in Biotech
There is a very interesting study out of Biotechnology Industry Organization (BIO) which was conducted with Thomson Reuters to look at the investor views of the biotech sector and the expectations for...
View ArticleUnusual Number of 52-Week Highs in BioHealth Stocks (BCRX, CRIS, NKTR, OGXI,...
As you will see, there are many new 52-week highs out there in some drug and biotech names…. Some of this is on swine flu news despite a big drop in the stock market today, but here goes: BioCryst...
View ArticleFriday’s Top BioHealth Movers (ACOR, AVNR, CXM, LXRX, SVNT, SQNM, SPPI)
This has been a quiet trading day, but not in the land of biotech and medical technologies that comprise the BioHealth sector. These are this morning’s top movers in the group: Acorda Therapeutics,...
View ArticleVanda (VNDA) Leaps On Novartis Pharma News
Vanda Pharmaceuticals (NASDAQ:VNDA) moved up 14% to as the company disclosed that it has entered into an agreement with Novartis Pharma AG to commercialize and develop Fanapt (iloperidone), Vanda’s...
View Article10-Bagger Watch: Cyclacel Meets Biotech Trophy Hunters (CYCC)
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) was the latest example of trader, speculators and investors running out to pile into the next low-price small cap biotech stock in the quest for the...
View ArticleTalking Biotech ETFs: iShares Nasdaq Biochnology to $100 (IBB, OSIP, MDVN)
Today’s price moves in the biotech sector are quite different from what we saw earlier this week. A hostile merger via tender from Astellas for OSI Pharmaceuticals Inc. (NASDAQ: OSIP) got everyone up...
View ArticleVery Few 52-Week Highs in BioHealth (ACOR, ALTH, ARIA, AUXL, KERX, NPSP,...
The market has been putting new highs and new highs and yesterday there were about 1700 stocks (including warrants, ETFs, and other publicly traded non-common entities). What is interesting is that...
View ArticleClik here to view.
Outlook 2011: 2010 BioHealth Winners Part 1 (ARIA, CHTP, CYCC, ENMD, EXAS,...
2010 has so far lacked all of the juice that drove many biotech stocks exponentially higher in 2009. For starters, the start of this year was not initiated with a deadly round of panic selling and...
View ArticleClik here to view.
Outlook 2011, Part II: 2010 BioHealth Winners (AMRN, ILMN, INHX, JAZZ, NBIX,...
2011 is getting closer and closer, and we wanted to review some of the standout BioHealth winners for 2010 to see what their prospects are for 2011. The rounds of exponential gains seen in 2009 were...
View Article
